Get started
Author

Emdormi Rymbai

Observed names: R. EMDORMI, Rymbai, Emdormi
ORCID: 0000-0002-4540-1073
Observed ORCID: 0000-0002-4540-1073
OpenAlex ID: A5042064806
Evaluation of anti-inflammatory and anti-arthritic property of ethanolic extract of Clitoria ternatea
2020 · K.P. Swathi, Saravanan Jayaram, et al. · Chinese Herbal Medicines · 67
Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential
2023 · Dhritiman Roy, Shivaramakrishnan Balasubramanian, et al. · Cellular and Molecular Neurobiology · 24
PDF
Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases
2024 · Emdormi Rymbai, Deepa Sugumar, et al. · Cell Biochemistry and Function · 18
The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models
2023 · Emdormi Rymbai, Deepa Sugumar, et al. · Life Sciences · 18
Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma
2022 · Anusha Shreenidhi Bhat, Ningthoujam Anirudh Singh, et al. · Reproductive Sciences · 17
An Update on the Role of Nrf2 and its Activators in Diseases Associated with Oxidative Stress
2020 · DEEPA SUGUMAR, J. SARAVANAN, et al. · Indian Journal of Pharmaceutical Sciences · 12
PDF
Evaluation of anti-cancer, antioxidant and antimicrobial activities of Alstonia scholaris L
2020 · Ravula Nanditha, J Saravanan, et al. · Research Journal of Pharmacy and Technology · 11
Ropinirole, a potential drug for systematic repositioning based on side effect profile for management and treatment of breast cancer
2020 · Emdormi Rymbai, Deepa Sugumar, et al. · Medical Hypotheses · 10
Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease
2024 · Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, et al. · Toxicology and Applied Pharmacology · 9
Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson’s disease model
2024 · Dhritiman Roy, Shivaramakrishnan Balasubramanian, et al. · Journal of drug targeting · 8
Side effects based network construction and drug repositioning of ropinirole as a potential molecule for Alzheimer’s disease: an in-silico , in-vitro , and in-vivo study
2023 · Amritha Chakkittukandiyil, Saurav Chakraborty, et al. · Journal of Biomolecular Structure and Dynamics · 8
The identification of c-Abl inhibitors as potential agents for Parkinson’s disease: a preliminary in silico approach
2024 · Emdormi Rymbai, Dhritiman Roy, et al. · Molecular Diversity · 7
Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson’s disease
2024 · Monisha Arumugam, Ranjith Sanjeeve Pachamuthu, et al. · Molecular Diversity · 6
The Promotion of Antioxidant and Anti-Inflammatory Activity by Nrf2 Amplifier is A Potential Technique in Diabetic Wound Healing — A Review
2022 · Tharani Mohanasundaram, Vadivelan Ramachandran, et al. · Pharmaceutical Sciences · 6
PDF
Breaking barriers: targeted delivery of resveratrol in lung cancer using folate-integrated and pH-responsive hybrid nanocarriers
2025 · Sanjoy Das, Malay K. Das, et al. · Future Journal of Pharmaceutical Sciences · 5
PDF
Evaluation Of Aphrodisiac Activity Of Allium Sativum In Male Rats
2019 · Pooja V Warange, J. Saravanan, et al. · International journal of scientific and technology research · 5
Neuroprotective effects of farnesol on motor and cognitive impairment against 3- nitropropionic acid-induced Huntington’s disease
2021 · S. Deepa, Emdormi Rymbai, et al. · The Thai Journal of Pharmaceutical Sciences · 4
PDF
Computational phytochemical screening for Parkinson's disease therapeutics: c-Abl and beyond
2025 · Jesmina Yasmine, Piyong Sola, et al. · Computational Biology and Chemistry · 3
A preliminary study to identify existing drugs for potential repurposing in breast cancer based on side effect profile
2023 · Emdormi Rymbai, Deepa Sugumar, et al. · Drug Research · 3
Nuclear receptors and other molecular targets in type 2 diabetes mellitus
2023 · Deepa Sugumar, Emdormi Rymbai, et al. · Journal of Applied Pharmaceutical Science · 3
PDF
Temporal Unpredictability and Probabilistic Uncertainty Induced Anxiety in the Times of COVID-19 Pandemic
2022 · Saravanan Jayaram, Praveen Thaggikuppe Krishnamurthy, et al. · Indian Journal of Pharmaceutical Education and Research · 3
PDF
Using Link and Major System of Memory to Memorise, Remember and Recall Pharmaceutical Sciences Better
2020 · Saravanan Jayaram, Santhosh Kumar Ramajayam, et al. · Indian Journal of Pharmaceutical Education and Research · 3
PDF
Harnessing androgen receptor: Revolutionizing diabetes treatment in men with selective androgen receptor modulators
2024 · Deepa Sugumar, Emdormi Rymbai, et al. · Medical Hypotheses · 2
Modulation of Nrf2 by activation of estrogen receptor β as a therapeutic strategy to prevent cancer development and overcome inflammation-related drug resistance in breast cancer
2022 · Emdormi Rymbai, Deepa Sugumar, et al. · Pharmaceutical Sciences · 2
Drug Repurposing: A Paradigm Shift in Drug Discovery
2020 · Saravanan Jayaram, Emdormi Rymbai, et al. · International Journal of Applied Pharmaceutical Sciences and Research · 2
PDF
Works count: 35
Citation count: 257
H-index: 9
I10-index: 8
Year
Topic
Type